M. Tonnini

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma

F. Piscaglia, T. Pressiani, R. Sacco, 2023, Cancers.

TKIs in combination with immunotherapy for hepatocellular carcinoma

A. Granito, F. Tovoli, Bernardo Stefanini, 2023, Expert review of anticancer therapy.

Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib

M. Kudo, T. Kawaguchi, N. Nishida, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?

F. Tovoli, Bernardo Stefanini, M. Marseglia, 2022, Expert review of anticancer therapy.

Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders

F. Piscaglia, T. Pressiani, R. Sacco, 2021, Cancers.

Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement

F. Tovoli, M. Renzulli, Bernardo Stefanini, 2022, Expert review of anticancer therapy.

Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia

F. Piscaglia, I. Serio, L. Ielasi, 2023, World Journal of Hepatology.

Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy

T. Pressiani, F. Foschi, A. Granito, 2024, Current oncology.